Corporate InformationMembers

Founder, Representative Director
President and CEO, Chairman of the boardMasamitsu HarataMaster of Agriculture, Master of Business Administration

Experienced all the necessary elements for a start-up under a global environment, such as basic research in academia, clinical development at listed pharmaceutical companies in Japan and overseas, medical affairs, sales marketing and management prior to establishing Human Life CORD Co., Ltd.
Invited Teaching Staff Part-time Lecturer) at the Aging Research Field, Graduate School of Medical Science, Nagoya University

Director of Overseas Business PlanningAndy C. Ye

As a global management consultant, he has many connections in the U.S. and other parts of Asia. Multi-lingual. In charge of global business development, starting with the U.S.

Norio Tahara

Akira Nabeshima

Hiroshi Ishiai

Yoshihiro Kidachi

Tetsuo Yamanaka

Nobutoshi Matsushita

ManagementMasamitsu HarataMaster of Agriculture, Master of Business Administration

Targeting therapy for intractable leukemia was studied as a researcher of the former Ministry of International Trade and Industry Institute of Industrial Science and Technology, and international results were obtained.
Experienced in the three elements necessary for the drug discovery bio start-up (basic research experience in academia/general administration of clinical development at a pharmaceutical company/management in bioventures) and global business experience.
Founded Human Life CORD Japan Inc. in April 2017, President and Representative Director

R&DMasamichi YamadaMaster of Engineering

Senior professional with extensive experience in drug research and development in the area of rare diseases. Prior to joining our team, he provided leadership and strategic vision at several global pharmaceutical companies. With a strong commitment to bringing cell therapy, a cutting-edge treatment modality, to patients, his team drives R&D and product launch in Human Life CORD.

Reliability AssuranceAkira FutakataPharmacist

Experienced regulatory affairs and quality assurance at various major chemical companies and pharmaceutical companies in Japan before joining our team.
Participated in the establishment of the organization for reliability assurance twice as a result of the company mergers, and experienced the three roles (Supervisor general, QA manager, and safety manager) at each company.
Responsible for regulatory filings and quality assurance for pharmaceutical formulations/active pharmaceutical ingredients, medical devices, and in vitro diagnostics, and has experience in launching new item products.
Provides business and management strategy support to management and is involved in business plan formulation

ManufacturingKentaro OkamuraPh.D. (Medicine)

Joined our team after experiences cell biology research at Japanese and overseas research institutes, research and development at Japanese and overseas multiple bio startup company, and cell manufacturing for regenerative medicine.
In collaboration with the Institute of Medical Science, the University of Tokyo, responsible for all aspects of manufacturing, such as launch and managiment of cell processing facilities, manufacture of investigational products, CMC regulatory, technology transfer to CMO, and manufacturing technology development.

Management Strategy and Business DevelopmentAkihito NakataPh.D. (Pharmacy), Pharmacist

Joined our team after experience at a foreign consulting firm, and supporting and investing in ventures in the fields of life sciences and healthcare.
In management consulting, he leads new businesses for major Japanese and overseas pharmaceutical and medical device companies, R&D, support for formulation and execution of organizational strategies, and various business reform projects.
In support of ventures, the company provides end-to-end support for Japanese business development activities of over 20 drug discovery ventures from Europe and the U.S.
Executive Director, NPO Corp. IHL/ Healthcare Leadership Study Group

CorporateYosuke Kotaki

After founding a medical and welfare-related company, he joined us after experiencing the management planning, accounting, finance, general affairs, legal affairs, etc. of JQ listed IT companies (now Prime Market) and JQ listed pharmaceutical companies (now TSE Growth Market).
Involved in M&A, financing, and formulating and executing medium-term business plans from the standpoint of both managers and employees, and contributes to improving business performance and achieve results by building an in-house sales system for drugs